Mineralys Therapeutics, Inc.

NASDAQ:MLYS

Biotechnology

Healthcare
$14.16 +1.49%

+$0.37 today

Market cap
$1.25B
Beta
0.56
P/E (TTM)
-13.9
EPS (TTM)
-$1.83
52W Low $12.59High $47.65

Volume 1.17M

Average 1.48M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$170.60M

FY 2025 · Annual

Net Income

-$154.65M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development16.31M26.25M70.36M168.58M132.01M
Selling, General & Admin2.42M5.23M14.3M23.82M38.6M
Operating Expenses18.73M31.48M84.66M192.4M170.6M
Depreciation & Amortization00043K59K
EBITDA(19.38M)(28.12M)(71.9M)(177.77M)(154.59M)
EBITDA Margin—————
Operating Income(18.73M)(31.48M)(84.66M)(192.4M)(170.6M)
Operating Margin—————
Interest Income01.68M12.76M14.59M15.95M
Interest Expense27K1.68M000
Other Income / Expenses(683K)1.68M12.76M14.59M15.95M
Income Before Tax(19.41M)(29.8M)(71.9M)(177.81M)(154.65M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(19.41M)(29.8M)(71.9M)(177.81M)(154.65M)
Net Margin—————
EPS (Basic)(3.89)(5.77)(1.99)(3.66)(2.29)
EPS (Diluted)(3.89)(5.77)(1.99)(3.66)(2.29)
Weighted Avg Shares4.98M5.17M36.19M48.54M67.66M
Weighted Avg Shares (Diluted)4.98M5.17M36.19M48.54M67.66M

MLYS Earnings Waterfall · TTM

NASDAQ:MLYS · Revenue to Net Income

Key Ratios

EPS$-4.24
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-14.4
P/S Ratio0.0

Analysis

$0 of revenue converted into -$349.6M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-4.24, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
8-KCurrent reportOct 29, 2026
4Statement of changes in beneficial ownershipOct 20, 2026
4Statement of changes in beneficial ownershipOct 20, 2026

How much revenue does MLYS generate?

Mineralys Therapeutics, Inc. (MLYS) reported $0.00 of revenue in fiscal 2025.

Is MLYS profitable?

Mineralys Therapeutics, Inc. (MLYS) reported -$154.65M of net income.